Domestic:+91 8550986868sales@anantlabs.com
LoginSign up
/
Anant Labs

Letrozole

CAS 112809-51-5

Letrozole
In Stock

Letrozole

Cat. No. ANT-LTZ-000CAS 112809-51-5In Stock
Technical Data
Cat. No.ANT-LTZ-000
CAS112809-51-5
Mol. FormulaC17H11N5
Mol. Weight285.3 g/mol
IUPAC4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
SMILESC1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
InChIInChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H
InChI KeyHPJKCIUCZWXJDR-UHFFFAOYSA-N
Purity99%
Description

Overview

Letrozole is an aromatase inhibitor sold under the brand name Femra, which is used to treat hormone-responsive breast cancer after surgery. It was patented in 1986 and approved for medical use in 1996

Anant Labs manufacture and furnish high quality Letrozole impurities for global markets. Our Letrozole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

4,4`-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrileletrozole112809-51-5FemaraLetrozolCGS 20267CGS-20267Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.